U.S. agency safeguarding public health through foods, drugs, and medical devices.
The Wegovy weight‑loss pill has seen surging demand in the United States, with millions of prescriptions and ongoing competition as Lilly and Novo Nordisk fight to broaden their GLP‑1 offerings. Regulators in the UK and UAE have approved oral Wegovy, while the NHS awaits cost‑effectiveness assessments, signaling a widening global access landscape.
The FDA has identified Raw Farm’s raw cheddar cheese as the likely source of a multistate E. coli outbreak affecting five people in California, one in Florida and one in Texas since Sept. 2025. Raw Farm has declined to recall its products, while investigators collect samples and pursue a definitive source.
Raw Farm of Fresno, California, is voluntarily recalling over 170,000 pounds of raw milk cheddar cheese due to E. coli concerns linked to an outbreak that has sickened nine people across three states, including young children. The farm denies the connection and refuses a recall, raising ongoing safety and regulatory questions.
A Louisiana judge declined to block telehealth prescriptions for mifepristone, citing ongoing FDA reviews. The case highlights tensions between state bans and federal regulations, with legal challenges and political implications ongoing as anti-abortion groups push for restrictions.
Recent studies have shown significant advances in gene therapy for hearing loss and eye conditions, as well as promising research on reversing brain inflammation linked to aging. Meanwhile, new evidence questions the effectiveness of Alzheimer’s drugs, highlighting ongoing challenges in neurodegenerative treatments. Today's date is Mon, 27 Apr 2026 11:37:39 +0100.
The US government has implemented new policies to accelerate research and development of psychedelics, including psilocybin, MDMA, and ibogaine. The move involves FDA fast-tracking and funding for state-level studies, aiming to improve treatments for mental health and addiction. This follows recent political and scientific developments.
USC researchers have found that young non-smokers with high-quality diets may have a higher incidence of early-onset lung cancer. The study analyzes 187 patients under 50 and links higher Healthy Eating Index scores to cancer biology that differs from smoking-related cases. Researchers point to possible pesticide exposure as a leading theory while noting ongoing questions.
The UK has passed the Tobacco and Vapes Act, which has created a rolling age ban that will permanently prevent anyone born on or after 1 January 2009 from legally buying tobacco. The law has also granted ministers broad powers to regulate vaping — including flavours, packaging, displays and where vaping is allowed — and will tighten sales rules for under‑18s.
President Trump has acknowledged that his previous claims of reducing drug prices by over 100% are mathematically impossible. During a drug pricing event, he explained his use of different calculation methods and defended his efforts to lower medication costs through new deals with pharmaceutical companies, including Regeneron.
A unanimous 5th Circuit ruling has blocked mail distribution of mifepristone, requiring in-person dispensing at clinics. The decision, which has immediate effect and is likely to be appealed to the Supreme Court, challenges FDA regulations as a breach of state bans and raises questions about access to medication abortion nationwide.
The Supreme Court is weighing an emergency petition to pause a Fifth Circuit ruling that would restrict mifepristone access, while allowing telemedicine and mail delivery to continue for now. The government and manufacturers urge a rapid decision, as lower-court moves threaten broad abortion access.
Health guidance has shifted to emphasize animal proteins and nutrient density, while hospitals have previously implemented plant-forward meals. The new federal guidelines prioritize animal sources and warn about potential gaps in plant-based diets, provoking debate among clinicians and policy-makers.
The Supreme Court has issued an emergency order keeping mifepristone available by mail and via telehealth while litigation continues. The action preserves access as lawsuits challenge FDA rules on prescribing the abortion pill, with a ruling likely not until next year.
Since 2025, measles outbreaks have spread in unvaccinated communities in the United States, prompting therapeutic research and policy debates. Outbreaks have climbed nationally, with California and other states reporting rising case counts and hospitalizations. Experts warn that misinformation compounds transmission, while high vaccination coverage remains vital for herd immunity.
GSK has struck a multi-billion deal to acquire Nuvalent, adding three late-stage cancer drugs to its portfolio, including two lung-cancer therapies under FDA review. The acquisition aims to boost sales growth, expand the lung-cancer platform, and position GSK for a potential rise in annual revenue by 2031.
The FDA has approved bemotrizinol (BEMT) for over‑the‑counter sunscreens, a move hailed as a major modernization. The ingredient blocks both UVA and UVB rays, is photostable, and will be sold under Parsol Shield before broader market adoption after 18 months. Experts say the update will improve protection and user experience, though supply and formulation timelines remain a factor.
The FDA has approved bemotrizinol, a chemical UV filter used in European and Asian sunscreens for over 20 years. It offers UVA and UVB protection, is photostable, and may lead to more elegant, higher-SPF products in the US. The move comes after decades of FDA inaction on new filters, with products containing bemotrizinol expected to reach US shelves after about 18 months.
A new CMS rule redefines medical frailty for Medicaid expansions, threatening to bar exemptions for some patients who are too sick to work. The guidance requires proof that conditions “significantly impair” work ability, potentially affecting many patients who rely on treatment while facing complex paperwork and renewal hurdles.
Health officials are raising awareness of alpha-gal syndrome, a meat allergy triggered by tick bites. The condition has emerged over roughly 15 years, with cases increasing as lone star ticks spread. Regulators have approved the first therapies, expanding options beyond avoidance and epinephrine. Seafood and poultry remain safe.